Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €6.55 EUR
Change Today +0.242 / 3.84%
Volume 737.0
ADA On Other Exchanges
Symbol
Exchange
Frankfurt
As of 3:32 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael D. Kishbauch

Director and Chairman of Strategy & Corporate Development Committee,Achillion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 41 board members in 3 different organizations across 6 different industries.

See Board Relationships
66$305,922

Background*

Mr. Michael D. Kishbauch, also known as Mike, served as the Chief Executive Officer and President of Achillion Pharmaceuticals, Inc. from July 2004 to May 2013. Mr. Kishbauch founded of OraPharma, Inc., and served as its President and Chief Executive Officer since September 1996 and again from September 2000 to July 2004. He joined J&J and served as its President of the OraPharma division. He served as President and Chief Operating Officer at two business units at Nelson ...

Read Full Background

Corporate Headquarters*

300 George Street
New Haven, Connecticut 06511

United States

Phone: 203-624-7000
Fax: 203-624-7003

Board Members Memberships*

2004-Present
Director and Chairman of Strategy & Corporate Development Committee
2013-Present
Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee
2014-Present
Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee

Education*

BA
Wesleyan University
MBA
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$50,000
Total Calculated Compensation$305,922
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ADA:GR €6.55 EUR +0.242

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.1M GBP
M. Michelle Berrey M.D., MPH.Chief Executive Officer, President, Chief Medical Officer and Director
Chimerix, Inc.
$419.3K
John M. Gill CPAChief Executive Officer, President and Director
PharmAthene, Inc.
--
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee
Emergent BioSolutions, Inc.
$1.2M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACHILLION PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.